BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27765016)

  • 1. The addition of S100B to guidelines for management of mild head injury is potentially cost saving.
    Calcagnile O; Anell A; Undén J
    BMC Neurol; 2016 Oct; 16(1):200. PubMed ID: 27765016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical validation of S100B use in management of mild head injury.
    Calcagnile O; Undén L; Undén J
    BMC Emerg Med; 2012 Oct; 12():13. PubMed ID: 23102492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Scandinavian guidelines for initial management of minimal, mild and moderate traumatic brain injury in adults.
    Undén L; Calcagnile O; Undén J; Reinstrup P; Bazarian J
    BMC Med; 2015 Dec; 13():292. PubMed ID: 26645914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury.
    Lagerstedt L; Egea-Guerrero JJ; Bustamante A; Montaner J; Rodríguez-Rodríguez A; El Rahal A; Turck N; Quintana M; García-Armengol R; Prica CM; Andereggen E; Rinaldi L; Sarrafzadeh A; Schaller K; Sanchez JC
    PLoS One; 2017; 12(4):e0175572. PubMed ID: 28419114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100B levels are affected by older age but not by alcohol intoxication following mild traumatic brain injury.
    Calcagnile O; Holmén A; Chew M; Undén J
    Scand J Trauma Resusc Emerg Med; 2013 Jul; 21():52. PubMed ID: 23830006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Validation of the Scandinavian Guidelines for Initial Management of Minimal, Mild, and Moderate Head Injuries in Adults.
    Minkkinen M; Iverson GL; Kotilainen AK; Pauniaho SL; Mattila VM; Lehtimäki T; Berghem K; Posti JP; Luoto TM
    J Neurotrauma; 2019 Oct; 36(20):2904-2912. PubMed ID: 31111795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of S100 calcium binding protein B serum levels in different types of traumatic intracranial lesions.
    Wolf H; Frantal S; Pajenda G; Leitgeb J; Sarahrudi K; Hajdu S
    J Neurotrauma; 2015 Jan; 32(1):23-7. PubMed ID: 25068442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study - "the PreTBI I study".
    Seidenfaden SC; Kjerulff JL; Juul N; Kirkegaard H; Møller MF; Münster AB; Bøtker MT
    Scand J Trauma Resusc Emerg Med; 2021 Jun; 29(1):75. PubMed ID: 34078435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100B outperforms clinical decision rules for the identification of intracranial injury on head CT scan after mild traumatic brain injury.
    Jones CMC; Harmon C; McCann M; Gunyan H; Bazarian JJ
    Brain Inj; 2020 Feb; 34(3):407-414. PubMed ID: 32064945
    [No Abstract]   [Full Text] [Related]  

  • 10. NRGN, S100B and GFAP levels are significantly increased in patients with structural lesions resulting from mild traumatic brain injuries.
    Çevik S; Özgenç MM; Güneyk A; Evran Ş; Akkaya E; Çalış F; Katar S; Soyalp C; Hanımoğlu H; Kaynar MY
    Clin Neurol Neurosurg; 2019 Aug; 183():105380. PubMed ID: 31234132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing head computed tomography after mild traumatic brain injury: Screening value of clinical findings and S100B protein levels.
    Asadollahi S; Heidari K; Taghizadeh M; Seidabadi AM; Jamshidian M; Vafaee A; Manoochehri M; Shojaee AH; Hatamabadi HR
    Brain Inj; 2016; 30(2):172-8. PubMed ID: 26671496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of biomarker S100B and guideline adherence in routine care of mild head trauma.
    Faisal M; Vedin T; Edelhamre M; Forberg JL
    Scand J Trauma Resusc Emerg Med; 2023 Jan; 31(1):3. PubMed ID: 36624501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interest of blood biomarkers to predict lesions in medical imaging in the context of mild traumatic brain injury.
    Bouvier D; Oris C; Brailova M; Durif J; Sapin V
    Clin Biochem; 2020 Nov; 85():5-11. PubMed ID: 32781055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Biomarker S100B and Mild Traumatic Brain Injury: A Meta-analysis.
    Oris C; Pereira B; Durif J; Simon-Pimmel J; Castellani C; Manzano S; Sapin V; Bouvier D
    Pediatrics; 2018 Jun; 141(6):. PubMed ID: 29716980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic approach to the mild head trauma of the adult in Emergency Medicine: between biomarkers and imaging].
    Lippi G; Cervellin G
    Recenti Prog Med; 2013 Mar; 104(3):120-32. PubMed ID: 23548957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can low serum levels of S100B predict normal CT findings after minor head injury in adults?: an evidence-based review and meta-analysis.
    Undén J; Romner B
    J Head Trauma Rehabil; 2010; 25(4):228-40. PubMed ID: 20611042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of biomarker S100B for traumatic brain damage in the emergency department may change observation strategy.
    Hansen-Schwartz J; Bouchelouche PN
    Dan Med J; 2014 Sep; 61(9):A4894. PubMed ID: 25186536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker S100B in plasma a screening tool for mild traumatic brain injury in an emergency department.
    H Hopman J; A L Santing J; A Foks K; J Verheul R; M van der Linden C; L van den Brand C; Jellema K
    Brain Inj; 2023 Jan; 37(1):47-53. PubMed ID: 36397287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of S100B protein serum measurement in detecting intracranial injury in children with mild head trauma.
    Manzano S; Holzinger IB; Kellenberger CJ; Lacroix L; Klima-Lange D; Hersberger M; La Scala G; Altermatt S; Staubli G
    Emerg Med J; 2016 Jan; 33(1):42-6. PubMed ID: 26283067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining H-FABP and GFAP increases the capacity to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury.
    Lagerstedt L; Egea-Guerrero JJ; Bustamante A; Rodríguez-Rodríguez A; El Rahal A; Quintana-Diaz M; García-Armengol R; Prica CM; Andereggen E; Rinaldi L; Sarrafzadeh A; Schaller K; Montaner J; Sanchez JC
    PLoS One; 2018; 13(7):e0200394. PubMed ID: 29985933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.